ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC11002-25mg |
|
50908-62-8 |
5'-(N-Cyclopropyl)carboxamidoadenosine
|
0 | C13H16N6O4 | |
GC11002-10mg |
|
50908-62-8 |
5'-(N-Cyclopropyl)carboxamidoadenosine
|
0 | C13H16N6O4 | |
GC11002-5mg |
|
50908-62-8 |
5'-(N-Cyclopropyl)carboxamidoadenosine
|
0 | C13H16N6O4 | |
GC11002-1mg |
|
50908-62-8 |
5'-(N-Cyclopropyl)carboxamidoadenosine
|
0 | C13H16N6O4 | |
GC11001-50mg |
|
3343-39-3 |
2-Pyridylethylamine dihydrochloride
|
0 | C7H10N2.2HCl | |
GC11000-25mg |
|
132196-28-2 |
Eicosapentaenoyl PAF C-16
|
0 | C44H80NO7P | |
GC11000-10mg |
|
132196-28-2 |
Eicosapentaenoyl PAF C-16
|
0 | C44H80NO7P | |
GC11000-5mg |
|
132196-28-2 |
Eicosapentaenoyl PAF C-16
|
0 | C44H80NO7P | |
GC11000-1mg |
|
132196-28-2 |
Eicosapentaenoyl PAF C-16
|
0 | C44H80NO7P | |
GC10999-10mM (in 1mL DMSO) |
|
166518-60-1 |
Avasimibe
|
0 | C29H43NO4S | |
GC10999-50mg |
|
166518-60-1 |
Avasimibe
|
0 | C29H43NO4S | |
GC10999-200mg |
|
166518-60-1 |
Avasimibe
|
0 | C29H43NO4S | |
GC10999-10mg |
|
166518-60-1 |
Avasimibe
|
0 | C29H43NO4S | |
GC10998-10mM (in 1mL DMSO) |
|
865773-15-5 |
PF-03084014
|
0 | C27H41F2N5O | |
GC10998-50mg |
|
865773-15-5 |
PF-03084014
|
0 | C27H41F2N5O | |
GC10998-25mg |
|
865773-15-5 |
PF-03084014
|
0 | C27H41F2N5O | |
GC10998-10mg |
|
865773-15-5 |
PF-03084014
|
0 | C27H41F2N5O | |
GC10998-5mg |
|
865773-15-5 |
PF-03084014
|
0 | C27H41F2N5O | |
GC10997-10mM (in 1mL DMSO) |
|
126-27-2 |
Oxethazaine
|
0 | C28H41N3O3 | |
GC10997-5g |
|
126-27-2 |
Oxethazaine
|
0 | C28H41N3O3 | |